GALPHARMA CO., LTD.
4Patents
3Active
4Granted
38Portfolio score
Filing activity: Mar 29, 2005 → Sep 29, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8268324B2 | Modified galectin 9 proteins and use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8580743B2 | Modified galectin 9 proteins and methods of treatment using them | Emerging Cross-Sectional Technologies | 1 | Active |
| US9493741B2 | Method for increasing the proportion of animal cells secreting galectin-9 | General | 0 | Revoked |
| US9528089B2 | Method for increasing the proportion of animal cells secreting galectin-9 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.